Asset Details
Do you wish to reserve the book?
T1 and T2 quantification using magnetic resonance fingerprinting in mild traumatic brain injury
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
T1 and T2 quantification using magnetic resonance fingerprinting in mild traumatic brain injury
Do you wish to request the book?
T1 and T2 quantification using magnetic resonance fingerprinting in mild traumatic brain injury
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
T1 and T2 quantification using magnetic resonance fingerprinting in mild traumatic brain injury
2022
Overview
Objectives
To assess whether MR fingerprinting (MRF)–based relaxation properties exhibit cross-sectional and prospective correlations with patient outcome and compare the results with those from DTI.
Methods
Clinical imaging, MRF, and DTI were acquired in patients (24 ± 10 days after injury (timepoint 1) and 90 ± 17 days after injury (timepoint 2)) and once in controls. Patient outcome was assessed with global functioning, symptom profile, and neuropsychological testing. ADC and fractional anisotropy (FA) from DTI and T
1
and T
2
from MRF were compared in 12 gray and white matter regions with Mann–Whitney tests. Bivariate associations between MR measures and outcome were assessed using the Spearman correlation and logistic regression.
Results
Data from 22 patients (38 ± 12 years; 17 women) and 18 controls (32 ± 8 years; 12 women) were analyzed. Fourteen patients (37 ± 12 years; 11 women) returned for timepoint 2, while two patients provided only timepoint 2 clinical outcome data. At timepoint 1, there were no differences between patients and controls in T
1
, T
2
, and ADC, while FA was lower in mTBI frontal white matter. T
1
at timepoint 1 and the change in T
1
exhibited more (
n
= 18) moderate to strong correlations (|
r
|= 0.6–0.85) with clinical outcome at timepoint 2 than T
2
(
n
= 3), FA (
n
= 7), and ADC (
n
= 2). High T
1
at timepoint 1, and serially increasing T
1
, accounted for five of the six MR measures with the highest utility for identification of non-recovered patients at timepoint 2 (AUC > 0.80).
Conclusion
T
1
derived from MRF was found to have higher utility than T
2
, FA, and ADC for predicting 3-month outcome after mTBI.
Key Points
•
In a region-of-interest approach, FA, ADC, and T
1
and T
2
all showed limited utility in differentiating patients from controls at an average of 24 and 90 days post-mild traumatic brain injury.
•
T
1
at 24 days, and the serial change in T
1
, revealed more and stronger predictive correlations with clinical outcome at 90 days than did T
2
, ADC, or FA.
•
T
1
showed better prospective identification of non-recovered patients at 90 days than ADC, T
2
, and FA.
